Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Asset Utilization Ratio (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Asset Utilization Ratio over the past 15 years, most recently at 0.54 for Q2 2025.

  • For Q2 2025, Asset Utilization Ratio rose 5.35% year-over-year to 0.54; the TTM value through May 2025 reached 0.54, up 5.35%, while the annual FY2025 figure was 0.52, 3.37% up from the prior year.
  • Asset Utilization Ratio for Q2 2025 was 0.54 at Lifecore Biomedical, Inc. \De\, up from 0.53 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.54 in Q2 2025 and troughed at 0.24 in Q2 2021.
  • A 5-year average of 0.42 and a median of 0.42 in 2023 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: plummeted 83.12% in 2021 and later surged 65.85% in 2022.
  • Year by year, Asset Utilization Ratio stood at 0.28 in 2021, then surged by 44.16% to 0.4 in 2022, then increased by 13.83% to 0.46 in 2023, then rose by 13.97% to 0.52 in 2024, then rose by 3.67% to 0.54 in 2025.
  • Business Quant data shows Asset Utilization Ratio for LFCR at 0.54 in Q2 2025, 0.53 in Q1 2025, and 0.52 in Q4 2024.